# Multi-omics analysis reveals STING activation mediates NLRP3-related pyroptosis and exacerbates myocardial ischemia-reperfusion injury

**Authors:** Xuehu Zhang, Aoqin Gu, Lirong Zhou, Yuru Ma, Peng Wu, Baozhen Zhu, Ru Yan, Guangzhi Cong, Xueping Ma, Shaobin Jia

PMC · DOI: 10.1371/journal.pone.0341839 · PLOS One · 2026-02-06

## TL;DR

This study shows that STING activation worsens heart damage after blood flow is restored following a heart attack, by triggering inflammation and cell death.

## Contribution

The study identifies STING as a mediator of NLRP3-related pyroptosis in myocardial ischemia-reperfusion injury, offering a new therapeutic target.

## Key findings

- STING activation increases oxidative stress and NLRP3 inflammasome activity, worsening heart injury.
- STING inhibition reduces inflammation and improves cardiac function in I/R models.
- Pyroptosis-related genes are dysregulated in I/R, with elevated scores in cardiomyocytes and inflammatory cells.

## Abstract

Myocardial ischemia-reperfusion injury (I/R) significantly exacerbates cardiomyocyte damage post-recanalization therapy in acute myocardial infarction. Pyroptosis and the NLRP3 inflammasome are crucial in I/R, yet the precise mechanism remains unclear.

Transcriptomics, proteomics, and single-cell transcriptomics were employed to examine cellular subtype changes and pyroptosis-associated gene regulation in I/R. Differential pyroptosis-related genes were identified from transcriptomics data and validated with proteomics. Single-cell RNA sequencing assessed pyroptosis levels and intercellular communication. Mouse myocardial I/R and human cardiomyocyte hypoxia/reoxygenation (H/R) models were used to explore STING overexpression/silencing effects on NLRP3 inflammasome activation, oxidative stress, and cellular injury.

Pyroptosis-related genes were significantly dysregulated, implicating multiple inflammatory pathways. Single-cell analyses revealed increased granulocytes, macrophage infiltration, cardiomyocyte injury, and enhanced pyroptosis scores post-I/R. Cardiomyocytes, endothelial cells, and fibroblasts exhibited increased pyroptosis and inflammatory cell-cell interactions. Animal studies indicated significant declines in cardiac function and increased oxidative stress and inflammation post-I/R. STING activation (SR717) worsened cardiac function, enhanced ROS production, and elevated myocardial injury markers; STING inhibition (H151) markedly mitigated these effects. Correspondingly, the cGAS-STING pathway and NLRP3 inflammasome factors were significantly upregulated post-I/R, exacerbated by STING agonists and alleviated by STING inhibitors. Cellular studies confirmed that STING overexpression intensified oxidative stress and pyroptosis, effects reversed by STING knockdown and blocked by NLRP3 inhibitor MCC950.

STING activation contributes to oxidative stress and NLRP3 inflammasome–associated pyroptosis during I/R. Targeting the STING-NLRP3 axis may represent a potential strategy to reduce myocardial injury after ischemia-reperfusion.

## Linked entities

- **Genes:** STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004]
- **Chemicals:** SR717 (PubChem CID 139434658), H151 (PubChem CID 7616033), MCC950 (PubChem CID 9910393)
- **Diseases:** myocardial infarction (MONDO:0005068)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, Tnnt2 (troponin T2, cardiac) [NCBI Gene 21956] {aka Tnt, cTnT}, Myh6 (myosin, heavy polypeptide 6, cardiac muscle, alpha) [NCBI Gene 17888] {aka A830009F23Rik, Myhc-a, Myhca, alpha-MHC, alphaMHC}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, Pros1 (protein S (alpha)) [NCBI Gene 19128], Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, Cdh5 (cadherin 5) [NCBI Gene 12562] {aka 7B4, Cd144, VE-Cad, VECD, VEcad, Vec}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, Cxcr2 (C-X-C motif chemokine receptor 2) [NCBI Gene 12765] {aka CD128, CDw128, Cmkar2, Gpcr16, IL-8Rh, IL-8rb}, Nox4 (NADPH oxidase 4) [NCBI Gene 50490], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Ptpn11 (protein tyrosine phosphatase, non-receptor type 11) [NCBI Gene 19247] {aka 2700084A17Rik, PTP1D, PTP2C, SAP-2, SH-PTP2, SH-PTP3}, Syk (spleen tyrosine kinase) [NCBI Gene 20963] {aka Sykb}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, Tbk1 (TANK-binding kinase 1) [NCBI Gene 56480] {aka 1200008B05Rik}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Axl (AXL receptor tyrosine kinase) [NCBI Gene 26362] {aka Ark, Tyro7, Ufo}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Dcn (decorin) [NCBI Gene 13179] {aka DC, DSPG2, PG40, PGII, PGS2, SLRR1B}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Brd4 (bromodomain containing 4) [NCBI Gene 57261] {aka Brd5, HUNK1, MCAP, WI-11513}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Dok2 (docking protein 2) [NCBI Gene 13449] {aka DokR, Frip, dok-R}, Nppb (natriuretic peptide type B) [NCBI Gene 18158] {aka BNF, BNP, Iso-ANP}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}, Ifnb1 (interferon beta 1, fibroblast) [NCBI Gene 15977] {aka IFN-beta, IFNB, If1da1, Ifb}, Nampt (nicotinamide phosphoribosyltransferase) [NCBI Gene 59027] {aka 1110035O14Rik, NAmPRTase, Pbef, Pbef1, Visfatin}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Gas6 (growth arrest specific 6) [NCBI Gene 14456] {aka Gas-6}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Pycard (PYD and CARD domain containing) [NCBI Gene 66824] {aka 9130417A21Rik, Asc, CARD5, TMS-1, TNS1, masc}, Calca (calcitonin/calcitonin-related polypeptide, alpha) [NCBI Gene 12310] {aka CA, CGRP-1, CGRP1, Calc, Calc1, Cgrp}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, Irf3 (interferon regulatory factor 3) [NCBI Gene 54131] {aka C920001K05Rik, IRF-3}, Actc1 (actin, alpha, cardiac muscle 1) [NCBI Gene 11464] {aka Actc-1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}
- **Diseases:** edema (MESH:D004487), function (MESH:D003291), acute inflammation (MESH:D007249), myocardial cell injury (MESH:D009202), /R (MESH:C580424), ear tags (MESH:D004427), ischemic necrosis (MESH:D005271), H/R (MESH:D000860), CVST (MESH:D012851), neuroinflammation (MESH:D000090862), cardiomyocyte injury (MESH:D014947), infarct (MESH:D007238), fracture (MESH:D050723), cardiac damage (MESH:D006331), death (MESH:D003643), ischemia (MESH:D007511), cardiovascular disease (MESH:D002318), AMI (MESH:D009203), atherosclerosis (MESH:D050197), fibrosis (MESH:D005355), myocardial structural injury (MESH:D020914), sepsis (MESH:D018805), I/R (MESH:D015427), degeneration (MESH:D009410), tumor (MESH:D009369), mitochondrial damage (MESH:D028361), microvascular obstruction (MESH:D017566), dislocation (MESH:D004204), cardiotoxicity (MESH:D066126), ischemic (MESH:D002545), cardiomyocyte damage (MESH:D020263), hypoxic (MESH:D002534), Myocardial ischemia (MESH:D017202), acute kidney injury (MESH:D058186), Myocardial necrosis (MESH:D009336), diabetic myocardium (MESH:D003920)
- **Chemicals:** DAPI (MESH:C007293), puromycin (MESH:D011691), xylene (MESH:D014992), urea (MESH:D014508), alcohol (MESH:D000438), cGAMP (MESH:C584311), MDA (MESH:D008315), MCC950 (MESH:C000597426), eosin (MESH:D004801), iron (MESH:D007501), SYBR Green (MESH:C098022), oxygen (MESH:D010100), sugar (MESH:D000073893), water (MESH:D014867), isoflurane (MESH:D007530), uranyl acetate (MESH:C005460), PVDF (MESH:C024865), H&amp;E (MESH:D006371), PBS (MESH:D007854), epoxy resin (MESH:D004853), H151 (-), Lipid (MESH:D008055), paraformaldehyde (MESH:C003043), isopropanol (MESH:D019840), GSH (MESH:D005978), Evans Blue (MESH:D005070), CO2 (MESH:D002245), iodoacetamide (MESH:D007460), NAD+ (MESH:D009243), paraffin (MESH:D010232), ethanol (MESH:D000431), glutaraldehyde (MESH:D005976), cholesterol (MESH:D002784), hematoxylin (MESH:D006416), DTT (MESH:D004229), SDS (MESH:D012967), DEPC (MESH:D004047), DMSO (MESH:D004121), polybrene (MESH:D006583)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Lentivirus (genus) [taxon 11646], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** AC16 — Homo sapiens (Human), Transformed cell line (CVCL_HA69), LV3-H1 — Homo sapiens (Human), Type 1 diabetes mellitus, Induced pluripotent stem cell (CVCL_B5RH), LV5 — Homo sapiens (Human), Lung small cell carcinoma, Cancer cell line (CVCL_0C20), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12880705/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12880705/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12880705/full.md

---
Source: https://tomesphere.com/paper/PMC12880705